Elevance Health Inc (NYSE: ELV) is 5.86% higher on its value in year-to-date trading and has touched a low of $362.21 and a high of $567.26 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ELV stock was last observed hovering at around $391.71 in the last trading session, with the day’s loss setting it -1.21%.
Currently trading at $390.50, the stock is -1.44% and 1.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.32 million and changing -0.31% at the moment leaves the stock -17.59% off its SMA200. ELV registered -23.82% loss for a year compared to 6-month loss of -28.14%.
The stock witnessed a 0.33% gain in the last 1 month and extending the period to 3 months gives it a -2.54%, and is 1.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.10% over the week and 2.50% over the month.
Elevance Health Inc (ELV) has around 104900 employees, a market worth around $90.57B and $176.81B in sales. Current P/E ratio is 15.25 and Fwd P/E is 10.00. Profit margin for the company is 3.38%. Distance from 52-week low is 7.81% and -31.16% from its 52-week high. The company has generated returns on investments over the last 12 months (8.48%).
The EPS is expected to grow by 4.42% this year
The shares outstanding are 231.92M, and float is at 231.46M with Short Float at 1.22%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 21.21 million shares valued at $11.49 billion. The investor’s holdings represent 9.1134 of the ELV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 20.7 million shares valued at $11.22 billion to account for 8.8976 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 11.65 million shares representing 5.0157 and valued at over $6.31 billion, while STATE STREET CORP holds 4.5471 of the shares totaling 10.56 million with a market value of $5.72 billion.
Elevance Health Inc (ELV) Insider Activity
The most recent transaction is an insider sale by Kendrick Charles Morgan JR, the company’s EVP & President, Commercial. SEC filings show that Kendrick Charles Morgan JR sold 7,417 shares of the company’s common stock on Oct 18 ’24 at a price of $432.14 per share for a total of $3.21 million. Following the sale, the insider now owns 8423.0 shares.
Still, SEC filings show that on Aug 05 ’24, PERU RAMIRO G (Director) disposed off 753 shares at an average price of $531.52 for $0.4 million. The insider now directly holds 8,744 shares of Elevance Health Inc (ELV).
